Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2024 Feb 14;130(5):892. doi: 10.1038/s41416-024-02606-w

Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

Theodora A Constantin 1, Anabel Varela-Carver 1, Kyle K Greenland 1, Gilberto Serrano de Almeida 1, Ellen Olden 1, Lucy Penfold 2, Simon Ang 1, Alice Ormrod 1, Damien A Leach 1, Chun-Fui Lai 1, Edward K Ainscow 3, Ash K Bahl 3, David Carling 2, Matthew J Fuchter 4, Simak Ali 1, Charlotte L Bevan 1,
PMCID: PMC10912197  PMID: 38355841

Correction to: British Journal of Cancer (2023) 128:2326-2337; 10.1038/s41416-023-02252-8, Article published online 19 April 2023

Following the original publication, the authors were notified of an error present in Figure 1, specifically Figure 1bii, where the same image file was used for CDK4 and CDK7.

The corrected version of Figure 1 is produced here.graphic file with name 41416_2024_2606_Figa_HTML.jpg

The authors provided the journal with the original data. The correction does not have any effect on the results or conclusions of the paper.

The original article has been corrected.


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES